Insider · CIK 0001568850

Giles Lisa M.

Reports to the SEC for 4 companies · MONTREAL

sec.gov

Transactions

Companies

Filings

CIK

0001568850

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+77K sh	—	—	77,000
2025-06-10	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-08-28	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-06-14	HCWBHCW Biologics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-02-20	HCWBHCW Biologics Inc.A Award	Director	AAward	+35.7K sh	$1.40	+$50K	35,815
2023-06-13	HCWBHCW Biologics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-07	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-07-05	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-15	HCWBHCW Biologics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.8K sh	—	—	41,841
2021-10-26	HCWBHCW Biologics Inc. · Stock OptionA Award	Director	AAward	+37K sh	—	—	37,037
2021-06-14	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-04-22	GenMark Diagnostics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−81.6K sh	$24.05	−$1.96M	0
2021-04-22	GenMark Diagnostics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,500 sh	$24.05	−$132K	0
2021-04-22	GenMark Diagnostics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.1K sh	—	—	0
2021-02-18	GenMark Diagnostics, Inc.A Award	Director	AAward	+7,782 sh	—	—	81,572
2020-10-01	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-05-29	GenMark Diagnostics, Inc.A Award	Director	AAward	+13.8K sh	—	—	73,790
2019-10-30	GenMark Diagnostics, Inc.A Award	Director	AAward	+528 sh	—	—	59,965
2019-07-31	GenMark Diagnostics, Inc.A Award	Director	AAward	+702 sh	—	—	59,437
2019-05-31	GenMark Diagnostics, Inc.A Award	Director	AAward	+17.9K sh	—	—	58,735
2018-05-24	GenMark Diagnostics, Inc.A Award	Director	AAward	+17.1K sh	—	—	40,798
2017-05-25	GenMark Diagnostics, Inc.A Award	Director	AAward	+6,981 sh	—	—	23,691
2016-08-12	GenMark Diagnostics, Inc.P Purchase	Director	PPurchase	+177 sh	$9.40	+$1,663.8	5,500
2016-08-12	GenMark Diagnostics, Inc.P Purchase	Director	PPurchase	+823 sh	$9.40	+$7,736.2	5,323
2016-05-26	GenMark Diagnostics, Inc.A Award	Director	AAward	+8,497 sh	—	—	16,710
2015-11-03	GenMark Diagnostics, Inc.P Purchase	Director	PPurchase	+4,000 sh	$6.60	+$26.4K	4,500
2015-05-28	GenMark Diagnostics, Inc.A Award	Director	AAward	+6,483 sh	—	—	8,213
2015-02-19	GenMark Diagnostics, Inc.A Award	Director	AAward	+1,730 sh	—	—	1,730
2015-02-19	GenMark Diagnostics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+19.1K sh	—	—	19,062
2014-11-17	Durata Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,875 sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.1K sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,575 sh	—	—	0
2013-12-03	Durata Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.95	+$11K	1,000
2013-05-16	Durata Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,875 sh	—	—	8,125
2013-05-16	Durata Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+11.1K sh	—	—	19,270
2012-08-06	Durata Therapeutics, Inc.P Purchase	Director	PPurchase	+500 sh	$8.25	+$4,125	1,500
2012-08-03	Durata Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,250 sh	$9.38	+$58.6K	6,250

Recent filings

Accepted (ET)
Jun 124
Giles Lisa M.0001568850-26-000002
SEC(opens sec.gov)
Jun 124
Giles Lisa M.0001415889-25-016931
SEC(opens sec.gov)
Aug 294
Giles Lisa M.0001415889-24-022534
SEC(opens sec.gov)
Jun 174
Giles Lisa M.0000950170-24-074365
SEC(opens sec.gov)
Feb 224
Giles Lisa M.0001209191-24-003785
SEC(opens sec.gov)
Jun 154
Giles Lisa M.0001209191-23-037420
SEC(opens sec.gov)
Jun 94
Giles Lisa M.0001209191-23-035836
SEC(opens sec.gov)
Aug 114
Giles Lisa M.0001209191-22-045471
SEC(opens sec.gov)
Jun 174
Giles Lisa M.0001209191-22-037849
SEC(opens sec.gov)
Oct 284
Giles Lisa M.0001209191-21-061922
SEC(opens sec.gov)
Jul 294
Giles Lisa M.0001209191-21-048565
SEC(opens sec.gov)
Apr 224
Giles Lisa M.0001487371-21-000182
SEC(opens sec.gov)
Feb 194
Giles Lisa M.0001487371-21-000049
SEC(opens sec.gov)
Oct 54
Giles Lisa M.0001209191-20-053839
SEC(opens sec.gov)
Jun 24
Giles Lisa M.0001487371-20-000191
SEC(opens sec.gov)
Nov 14
Giles Lisa M.0001487371-19-000224
SEC(opens sec.gov)
Aug 24
Giles Lisa M.0001487371-19-000170
SEC(opens sec.gov)
Jun 44
Giles Lisa M.0001487371-19-000161
SEC(opens sec.gov)

Companies

Address

C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420

MONTREAL, H4M 2X6